Published in J Virol on July 01, 1999
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol (2003) 4.11
Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J (2004) 4.05
Structures of immature flavivirus particles. EMBO J (2003) 3.62
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol (2001) 2.81
Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol (2004) 2.64
Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum. J Virol (2002) 1.95
Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion. J Cell Biol (2005) 1.88
Membrane interactions of the tick-borne encephalitis virus fusion protein E at low pH. J Virol (2002) 1.83
Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine. J Virol (2000) 1.79
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73
A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog (2011) 1.70
Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection. Expert Rev Mol Med (2008) 1.67
Substitutions at the putative receptor-binding site of an encephalitic flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycans in entry. J Virol (2000) 1.62
Dealing with low pH: entry and exit of alphaviruses and flaviviruses. Trends Microbiol (2009) 1.60
Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development. J Virol (2003) 1.55
Crystal structure of dengue virus type 1 envelope protein in the postfusion conformation and its implications for membrane fusion. J Virol (2009) 1.52
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol (2004) 1.50
Lipid interaction of the C terminus and association of the transmembrane segments facilitate atlastin-mediated homotypic endoplasmic reticulum fusion. Proc Natl Acad Sci U S A (2012) 1.46
Peptide inhibitors of dengue virus and West Nile virus infectivity. Virol J (2005) 1.41
Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. J Virol (2003) 1.38
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32
Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses. J Virol (2004) 1.27
Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol (2001) 1.23
Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol J (2007) 1.20
Characterization of a membrane-associated trimeric low-pH-induced Form of the class II viral fusion protein E from tick-borne encephalitis virus and its crystallization. J Virol (2004) 1.19
Degrees of maturity: the complex structure and biology of flaviviruses. Curr Opin Virol (2012) 1.15
Structure of a dengue virus envelope protein late-stage fusion intermediate. J Virol (2012) 1.12
Yellow fever virus replicons as an expression system for hepatitis C virus structural proteins. J Virol (2003) 1.11
Closing the door on flaviviruses: entry as a target for antiviral drug design. Antiviral Res (2008) 1.09
MicroRNA targeting of neurotropic flavivirus: effective control of virus escape and reversion to neurovirulent phenotype. J Virol (2012) 1.05
Molecular dissection of the Semliki Forest virus homotrimer reveals two functionally distinct regions of the fusion protein. J Virol (2002) 1.02
Flaviviruses: braking the entering. Curr Opin Virol (2013) 1.02
Functions of the stem region of the Semliki Forest virus fusion protein during virus fusion and assembly. J Virol (2006) 1.01
Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. J Virol (2014) 1.00
The length of and nonhydrophobic residues in the transmembrane domain of dengue virus envelope protein are critical for its retention and assembly in the endoplasmic reticulum. J Virol (2010) 0.99
Differences in the postfusion conformations of full-length and truncated class II fusion protein E of tick-borne encephalitis virus. J Virol (2005) 0.99
Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia. J Virol (2014) 0.98
Role of the transmembrane domains of prM and E proteins in the formation of yellow fever virus envelope. J Virol (2003) 0.97
The unique transmembrane hairpin of flavivirus fusion protein E is essential for membrane fusion. J Virol (2011) 0.94
Mutational analysis of the zippering reaction during flavivirus membrane fusion. J Virol (2011) 0.92
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry. J Biol Chem (2011) 0.91
Progress in the identification of dengue virus entry/fusion inhibitors. Biomed Res Int (2014) 0.91
Neuroadapted yellow fever virus 17D: determinants in the envelope protein govern neuroinvasiveness for SCID mice. J Virol (2003) 0.90
DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. PLoS One (2011) 0.89
Neuroadapted yellow fever virus 17D: genetic and biological characterization of a highly mouse-neurovirulent virus and its infectious molecular clone. J Virol (2001) 0.88
Sequential conformational rearrangements in flavivirus membrane fusion. Elife (2014) 0.88
Proteomics computational analyses suggest that baculovirus GP64 superfamily proteins are class III penetrenes. Virol J (2008) 0.88
The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry. J Virol (2011) 0.87
Unexpected structural features of the hepatitis C virus envelope protein 2 ectodomain. J Virol (2014) 0.87
Characterization of the GXXXG motif in the first transmembrane segment of Japanese encephalitis virus precursor membrane (prM) protein. J Biomed Sci (2010) 0.86
The C-terminal helical domain of dengue virus precursor membrane protein is involved in virus assembly and entry. Virology (2010) 0.86
The transmembrane domains of the prM and E proteins of yellow fever virus are endoplasmic reticulum localization signals. J Virol (2004) 0.85
Evolutionary Analysis of Dengue Serotype 2 Viruses Using Phylogenetic and Bayesian Methods from New Delhi, India. PLoS Negl Trop Dis (2016) 0.83
Mutagenesis of the DI/DIII linker in dengue virus envelope protein impairs viral particle assembly. J Virol (2012) 0.82
Molecular mechanism of pathogenesis of dengue virus: Entry and fusion with target cell. Indian J Clin Biochem (2005) 0.81
Synergistic interactions between the NS3(hel) and E proteins contribute to the virulence of dengue virus type 1. PLoS Negl Trop Dis (2012) 0.80
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections. Biomed Res Int (2013) 0.80
C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins. PLoS One (2012) 0.80
Production of immunogenic West Nile virus-like particles using a herpes simplex virus 1 recombinant vector. Virology (2016) 0.80
Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein. J Virol (2004) 0.80
Prevalence and phylogenetic analysis of tick-borne encephalitis virus (TBEV) in field-collected ticks (Ixodes ricinus) in southern Switzerland. Parasit Vectors (2014) 0.79
Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model. J Virol (2008) 0.79
Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc. PLoS Negl Trop Dis (2016) 0.79
Changing the protease specificity for activation of a flavivirus, tick-borne encephalitis virus. J Virol (2008) 0.78
Proteomics computational analyses suggest that the bornavirus glycoprotein is a class III viral fusion protein (gamma penetrene). Virol J (2009) 0.78
Structure-based mutational analysis of several sites in the E protein: implications for understanding the entry mechanism of Japanese encephalitis virus. J Virol (2015) 0.77
Systematic Bioinformatic Approach for Prediction of Linear B-Cell Epitopes on Dengue E and prM Protein. Adv Bioinformatics (2016) 0.75
Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes. PLoS Negl Trop Dis (2015) 0.75
Langat virus M protein is structurally homologous to prM. J Virol (2001) 0.75
Partial Characterization of Tick-Borne Encephalitis Virus Isolates from Ticks of Southern Ukraine. Vector Borne Zoonotic Dis (2017) 0.75
Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses. Am J Trop Med Hyg (1958) 40.44
Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol (1973) 33.51
Atomic structure of the ectodomain from HIV-1 gp41. Nature (1997) 16.31
Core structure of gp41 from the HIV envelope glycoprotein. Cell (1997) 16.18
Structure of influenza haemagglutinin at the pH of membrane fusion. Nature (1994) 14.61
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
HIV entry and its inhibition. Cell (1998) 9.42
A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol (1995) 7.30
Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol (1996) 5.83
Atomic structure of a thermostable subdomain of HIV-1 gp41. Proc Natl Acad Sci U S A (1997) 5.76
Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol (1996) 4.49
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Three-dimensional solution structure of the 44 kDa ectodomain of SIV gp41. EMBO J (1998) 3.77
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses. Cell (1996) 2.70
A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology (1998) 2.61
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein. Biochemistry (1995) 2.57
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides. Proc Natl Acad Sci U S A (1998) 2.46
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Cell-associated West Nile flavivirus is covered with E+pre-M protein heterodimers which are destroyed and reorganized by proteolytic cleavage during virus release. J Virol (1989) 2.38
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J Virol (1996) 2.33
Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology (2000) 2.09
Proper maturation of the Japanese encephalitis virus envelope glycoprotein requires cosynthesis with the premembrane protein. J Virol (1993) 1.97
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Enveloped viruses: a common mode of membrane fusion?. Curr Biol (1997) 1.80
A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J Biol Stand (1986) 1.62
Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr Biol (1995) 1.60
The central structural feature of the membrane fusion protein subunit from the Ebola virus glycoprotein is a long triple-stranded coiled coil. Proc Natl Acad Sci U S A (1998) 1.58
Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and preM and identification of a protective, non-neutralizing preM-specific monoclonal antibody. Virus Res (1996) 1.27
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine (1995) 1.26
Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR. Virus Genes (1994) 1.21
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology (1994) 3.82
Proteolytic activation of tick-borne encephalitis virus by furin. J Virol (1997) 3.78
Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. J Virol (1995) 3.67
Mutational evidence for an internal fusion peptide in flavivirus envelope protein E. J Virol (2001) 3.58
Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Mol Cell (2001) 3.23
Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J Virol (1995) 2.97
Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. J Virol (1996) 2.75
Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR. Biotechniques (1991) 2.64
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. J Gen Virol (1991) 2.34
Structural requirements for low-pH-induced rearrangements in the envelope glycoprotein of tick-borne encephalitis virus. J Virol (1996) 2.33
Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect (2004) 2.30
Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol (1999) 2.23
Spontaneous and engineered deletions in the 3' noncoding region of tick-borne encephalitis virus: construction of highly attenuated mutants of a flavivirus. J Virol (1998) 2.11
Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system. Virology (2000) 2.09
The flavivirus 3'-noncoding region: extensive size heterogeneity independent of evolutionary relationships among strains of tick-borne encephalitis virus. Virology (1995) 2.08
Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vivo. J Virol (2001) 1.94
Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. J Gen Virol (1981) 1.90
The flavivirus envelope protein E: isolation of a soluble form from tick-borne encephalitis virus and its crystallization. J Virol (1991) 1.80
Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. J Gen Virol (1997) 1.79
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site. J Virol (2000) 1.77
Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology (1989) 1.76
In vitro-synthesized infectious RNA as an attenuated live vaccine in a flavivirus model. Nat Med (1998) 1.75
Epitope mapping of flavivirus glycoproteins. Adv Virus Res (1986) 1.67
Secondary structure of the 3'-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA (1997) 1.62
A model study of the use of monoclonal antibodies in capture enzyme immunoassays for antigen quantification exploiting the epitope map of tick-borne encephalitis virus. J Biol Stand (1986) 1.62
Complete genomic sequence of Powassan virus: evaluation of genetic elements in tick-borne versus mosquito-borne flaviviruses. Virology (1993) 1.54
A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies. Virology (1983) 1.53
Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol (1990) 1.50
Characterization of monoclonal antibody-escape mutants of tick-borne encephalitis virus with reduced neuroinvasiveness in mice. J Gen Virol (1997) 1.45
Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J Clin Microbiol (1991) 1.38
Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. J Med Virol (1996) 1.34
Ageing abolishes the effects of fluoxetine on neurogenesis. Mol Psychiatry (2009) 1.28
Characterization and complete genome sequences of high- and low- virulence variants of tick-borne encephalitis virus. J Gen Virol (1996) 1.28
Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am J Respir Crit Care Med (1999) 1.26
Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine (1995) 1.26
Antibody-induced conformational changes result in enhanced avidity of antibodies to different antigenic sites on the tick-borne encephalitis virus glycoprotein. Virology (1984) 1.23
Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus. J Virol (2001) 1.23
Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR. Virus Genes (1994) 1.21
The interactions of the flavivirus envelope proteins: implications for virus entry and release. Arch Virol Suppl (1994) 1.20
A single amino acid substitution in envelope protein E of tick-borne encephalitis virus leads to attenuation in the mouse model. J Virol (1990) 1.19
Chemical crosslinking of tick-borne encephalitis virus and its subunits. J Gen Virol (1980) 1.19
Comparison of virtual phenotype and HIV-SEQ program (Stanford) interpretation for predicting drug resistance of HIV strains. HIV Med (2002) 1.17
A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J Immunol (1999) 1.17
Comparison of two different enzyme immunoassays for detection of immunoglobulin M antibodies against tick-borne encephalitis virus in serum and cerebrospinal fluid. J Clin Microbiol (1981) 1.17
Presence of poly(A) in a flavivirus: significant differences between the 3' noncoding regions of the genomic RNAs of tick-borne encephalitis virus strains. J Virol (1991) 1.14
Tick-borne encephalitis virus envelope protein E-specific monoclonal antibodies for the study of low pH-induced conformational changes and immature virions. Arch Virol (1995) 1.13
Sequence of the genes encoding the structural proteins of the low-virulence tick-borne flaviviruses Langat TP21 and Yelantsev. Virology (1991) 1.12
Nephropathia epidemica and Puumala virus in Austria. Eur J Clin Microbiol Infect Dis (1999) 1.10
Characterization of a disulphide bridge-stabilized antigenic domain of tick-borne encephalitis virus structural glycoprotein. J Gen Virol (1987) 1.10
Identification of tick-borne encephalitis virus ribonucleic acid in tick suspensions and in clinical specimens by a reverse transcription-nested polymerase chain reaction assay. Clin Diagn Virol (1995) 1.09
A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology (1999) 1.05
The entry machinery of flaviviruses. Arch Virol Suppl (2004) 1.05
Evaluation of the polymerase chain reaction for diagnosis of herpes simplex virus encephalitis. J Clin Microbiol (1993) 1.02
Studies on the glycosylation of flavivirus E proteins and the role of carbohydrate in antigenic structure. Virology (1987) 1.02
Monitoring the virus load can predict the emergence of drug-resistant hepatitis B virus strains in renal transplantation patients during lamivudine therapy. J Infect Dis (2000) 1.02
Formation of polymeric glycoprotein complexes from a flavivirus: tick-borne encephalitis virus. J Gen Virol (1980) 1.02
Problems in detection of cytomegalovirus in urine samples by dot blot hybridization. J Clin Microbiol (1987) 1.02
L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Sleep (1995) 1.01
The molecular biology of tick-borne encephalitis virus. Review article. APMIS (1993) 1.01
Isolation of dimeric glycoprotein subunits from tick-borne encephalitis virus. Intervirology (1980) 1.00
Presence of human herpesvirus 6 variants A and B in saliva and peripheral blood mononuclear cells of healthy adults. J Clin Microbiol (1996) 0.98
Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes. Vaccine (1992) 0.98
Antigenic and immunogenic properties of defined physical forms of tick-borne encephalitis virus structural proteins. Infect Immun (1981) 0.97
Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis. J Med Virol (1980) 0.94
Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J Infect Dis (1995) 0.92
Characterization of antigenic variants of tick-borne encephalitis virus selected with neutralizing monoclonal antibodies. J Gen Virol (1989) 0.92